Pharmacology
Progetti
- GPR21 receptor as an innovative pharmacological target for type 2 diabetes
- Development of a new model for integrated epidemiological analysis of drug-abuse in sports
- Molecular, pharmacological and functional characterization of the receptors for obestatin, a peptide coded by the ghrelin gene, in muscle satellite cells: in vitro ed in vivo studies for a novel potential therapeutical approach in the treatment of skeletal muscle pathologies
- Development of computational methods to predict protein succination
- Development of immuno-mediated pharmacotherapy models for melanoma
- Sonodynamic therapy: high energy shock waves and porphyrin compounds for treatment of solid tumors (SWP)
- In vivo sonodynamic therapy: evaluation of cavitation effects on cancer tissue with innovative sonosensitizers - CONCLUDED
- Preparation and Uses of Targeted Nanoparticles for Drug Delivery
- Biological effects of sonoluminescence
- Enhancing the therapeutic efficacy of doxorubicin by therapeutic ultrasound
- Evaluation of the efficacy o anti-H1 antihistamine drug(s) for diabetic nephroapthy
- Exploiting the biological effects of ultrasound-triggered gold nanoparticles
- H4 Histamine Receptor As A New Pharmacological Target For The Treatment Of Diabetic Nephropathy (HISDIAN)
- Neuroendocrine correlates of stress-induced depression
- Pharmacogenetic study of Carvedilol in Healthy volunteers
- Pharmacogenetic study of Tacrolimus in pediatric liver transplantation
- Pharmacological and Biochemical Characterization of TLQP-21 in CHO cell lines
- Understanding the molecular bases of secondary resistance to EGFR targeted therapies in colorectal cancer